
Mumbai: NCLT Approves ₹577.24-Crore Plan For Arch Pharmalabs Revival
The story in brief
NCLT approved a ₹577.24-crore resolution plan for Arch Pharmalabs Ltd, submitted by Ashish Kumar and MetaX Life Sciences. The plan includes ₹567.49 crore discharge and ₹9.75 crore CIRP costs. The resolution will provide ₹2 crore for workmen’s and employees’ claims in Mumbai and surrounding areas. Resolution applicants plan to complete payments within 75 days.